E

    Eton Pharmaceuticals Inc (ETON)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $60.44
    +0.66 (+1.10%)

    Market Cap: $1.73B

    Last updated: Sep 01, 2026 at 5:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    52%(15/29)
    Avg Surprise
    -44.04%
    Streak
    3 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$0.37
    Range$0.32 - $0.42
    2 analysts
    EPS Revisions
    1
    0
    7d
    1
    0
    30d
    EPS Estimate Drift
    90d ago$0.31-16.2%
    60d ago$0.31-16.2%
    30d ago$0.31-16.2%
    7d ago$0.31-16.2%
    Current$0.37
    Revenue Consensus
    $42M
    Range$41M - $43M
    4 analysts
    Period ending Dec 31, 2026
    EPS Consensus$0.70
    Range$0.58 - $0.82
    2 analysts
    Revenue Consensus
    $58M
    Range$56M - $61M
    4 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$0.70---
    Sep 26EST
    		-$0.37---
    Jun 26
    Reported Aug 6
    		$0.35$0.11+218.18%Beat+450.0%
    Mar 26
    Reported May 14
    		$0.14$0.14+0.00%Beat+333.3%
    Dec 25
    Reported Mar 19
    		$0.19$0.18+5.56%Beat+1050.0%
    Sep 25
    Reported Nov 6
    		$0.04N/A-75.00%Miss+100.0%
    Jun 25
    Reported Aug 7
    		$-0.10$-0.01-900.00%Miss+16.7%
    Mar 25
    Reported May 13
    		$-0.06$0.05-220.00%Miss-100.0%
    Dec 24
    Reported Mar 18
    		$-0.02$-0.00-506.06%Miss+77.8%
    Sep 24
    Reported Nov 12
    		$0.02$-0.01+300.00%Beat+200.0%
    Jun 24
    Reported Aug 8
    		$-0.12$-0.07-71.43%Miss-166.7%
    Mar 24
    Reported May 9
    		$-0.03N/A+57.14%Beat+70.0%
    Dec 23
    Reported Mar 14
    		$-0.09$-0.04-125.00%Miss-325.0%
    Sep 23
    Reported Nov 9
    		$-0.02N/A+80.00%Beat+83.3%
    Jun 23
    Reported Aug 10
    		$0.18$-0.09+300.00%Beat+400.0%
    Mar 23
    Reported May 11
    		$-0.10$-0.14+28.57%Beat+52.4%
    Dec 22
    Reported Mar 16
    		$0.04$0.01+300.00%Beat+0.0%
    Sep 22
    Reported Nov 10
    		$-0.12$-0.15+20.00%Beat+50.0%
    Jun 22
    Reported Aug 11
    		$-0.06$0.03-300.00%Miss+40.0%
    Mar 22
    Reported May 12
    		$-0.21$-0.08-162.50%Miss-210.5%
    Dec 21
    Reported Mar 16
    		$0.04N/A-78.95%Miss+112.5%
    Sep 21
    Reported Nov 15
    		$-0.24$-0.13-84.62%Miss+22.6%
    Jun 21
    Reported Aug 16
    		$-0.10$-0.14+28.57%Beat+56.5%
    Mar 21
    Reported May 13
    		$0.19$0.19+0.00%Beat+138.0%
    Dec 20
    Reported Mar 16
    		$-0.32$-0.26-23.08%Miss-113.3%
    Sep 20
    Reported Nov 12
    		$-0.31$-0.25-24.00%Miss-10.7%
    Jun 20
    Reported Aug 12
    		$-0.23$-0.26+11.54%Beat-27.8%
    Mar 20
    Reported May 14
    		$-0.50$-0.23-117.39%Miss-19.0%
    Dec 19
    Reported Mar 5
    		$-0.15$-0.26+42.31%Beat+89.9%
    Sep 19
    Reported Nov 14
    		$-0.28$-0.24-16.67%Miss+47.2%
    Jun 19
    Reported Aug 6
    		$-0.18$-0.28+35.71%Beat+21.7%
    Mar 19
    Reported May 7
    		$-0.42N/AN/ABeat-
    Dec 18
    Reported Mar 25
    		$-1.48N/AN/ABeat-
    Sep 18
    Reported Dec 20
    		$-0.53N/AN/ABeat-
    Jun 18
    Reported Aug 10
    		$-0.23$0.00N/AMiss-

    Key Metrics

    Valuation
    P/E Ratio83.94EV/EBITDA86.01x
    Price/FCF113.48xFCF Yield0.88%
    Profitability
    Profit Margin12.00%Operating Margin35.80%
    ROE36.00%ROIC21.79%
    Financial Health
    Debt/Equity0.60xInterest Coverage4.58x
    Current Ratio1.52xQuick Ratio1.30x
    Trading Statistics
    Beta0.87Avg Volume667.63K
    52-Week High$66.3752-Week Low$14.27

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$62.13
    SMA 20$54.63
    SMA 50$45.63
    SMA 200$27.41
    EMA 10$60.04
    EMA 20$56.13
    EMA 50$47.76
    EMA 200$31.95

    MACD

    Line: 5.23Signal: 5.24Hist: -0.01

    ADX

    ADX: 42.6+DI: 30.5-DI: 16.8

    Aroon & PSAR

    Aroon Up80.0
    Aroon Down44.0
    PSAR$56.73

    Bollinger Bands

    Upper Band$73.09
    Lower Band$36.17
    %B Position6759%(Upper)
    Band Width0.66

    RSI (14-Day)

    Neutral
    63.7

    Momentum Oscillators

    Stoch %K79.0
    Stoch %D82.3
    Williams %R-23.1
    ROC (10d)-2.1%
    Momentum-1.29
    CCI (20d)41.6
    MFI (14d)59.2

    Volatility Measures

    ATR (14d)$3.45(5.7%)
    StdDev (20d)9.23
    Hist Vol164.4%(High)

    Volume Flow

    VWAP$59.74
    OBV20.7M
    AD Line6.9M
    CMF (20d)0.166

    Volume Metrics

    Avg Vol (20d)677.5K
    Vol Ratio1.1x
    VWMA (20d)$56.53

    Pivot Points

    R3$65.62
    R2$63.87
    R1$61.82
    Pivot Point$60.08
    S1$58.03
    S2$56.28
    S3$54.24

    Advanced Oscillators

    TSI37.79
    Ultimate Osc59.7
    KST429.43

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$37.59M$24.27M$21.28M$22.46M$18.93M$17.28M$11.65M$10.32M$9.07M$7.97M$7.31M$7.03M
    Cost of Revenue$12.18M$9.53M$8.18M$14.60M$7.00M$7.42M$5.17M$4.02M$3.45M$2.96M$3.68M$2.63M
    Gross Profit$25.41M$14.73M$13.10M$7.86M$11.92M$9.86M$6.48M$6.30M$5.63M$5.01M$3.63M$4.40M
    Operating Expenses$12.62M$12.32M$10.64M$9.22M$13.40M$10.33M$5.85M$5.79M$8.56M$5.81M$5.62M$4.95M
    R&D$993,000$1.88M$1.78M$1.11M$3.71M$1.16M$-871,000$505,000$2.97M$651,000$1.05M$615,000
    SG&A$11.63M$10.45M$8.86M$8.11M$9.69M$9.17M$6.72M$5.29M$5.59M$5.16M$4.58M$4.34M
    Operating Income$12.79M$2.41M$2.46M$-1,363,000$-1,475,000$-470,000$629,000$509,000$-2,935,000$-800,000$-1,993,000$-548,000
    Interest Income$-1,076,000$-840,000$0$-592,000$-1,044,000$-1,028,000$0$-8,000$-52,000$-11,000$0$-31,000
    Interest Expense$1.08M$840,000$1.05M$592,000$1.04M$1.03M$1.14M$8,000$52,000$11,000$16,000$31,000
    Income Before Tax$11.72M$1.57M$1.41M$-1,955,000$-2,519,000$-1,498,000$-511,000$501,000$-2,987,000$-811,000$-2,009,000$-579,000
    Income Tax Expense$140,000$20,000$-69,000$-28,000$66,000$74,000$87,000$-126,000$54,000$0$247,000$0
    Net Income$11.58M$1.55M$1.48M$-1,927,000$-2,585,000$-1,572,000$-598,000$627,000$-3,041,000$-811,000$-2,256,000$-579,000
    EBITDA$14.34M$3.66M$3.66M$-175,000$-422,000$837,000$2.02M$809,000$-2,633,000$-541,000$-1,938,000$-328,000
    EBIT$12.79M$2.41M$2.46M$-1,363,000$-1,475,000$-470,000$629,000$509,000$-2,935,000$-800,000$-2,290,000$-548,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about ETON

    News

    34,027 Shares in Eton Pharmaceuticals, Inc. $ETON Acquired by Jefferies Financial Group Inc.

    Jefferies Financial Group Inc. acquired 34,027 shares of Eton Pharmaceuticals, Inc. (NASDAQ:ETON) in the second quarter, valued at approximately $1.23 million, giving them a 0.12% stake. The company reported strong Q2 earnings and revenue, exceeding analyst expectations. Despite a "Moderate Buy" consensus rating from analysts, there have been significant insider stock sales totaling $6.2 million over the past 90 days.

    MarketBeat•8/31/26•
    Somewhat-Bullish

    Navellier & Associates Inc. Makes New Investment in Eton Pharmaceuticals, Inc. $ETON

    Navellier & Associates Inc. has made a new investment in Eton Pharmaceuticals, acquiring 18,010 shares valued at approximately $652,000. Despite positive analyst sentiment and strong quarterly earnings, insider selling activity, totaling 125,000 shares worth $6.2 million, has also been noted. Institutional investors collectively own 27.86% of the company, with analysts maintaining an average "Moderate Buy" rating and a price target of $67.50.

    MarketBeat•8/30/26•
    Bullish

    Eton Pharmaceuticals, Inc. $ETON Stock Holdings Increased by Bank of America Corp DE

    Bank of America Corp DE significantly increased its holdings in Eton Pharmaceuticals (NASDAQ:ETON) by 37.8% in the first quarter, bringing its total stake to 144,367 shares valued at approximately $3.56 million. Other institutional investors also raised their positions, with overall institutional ownership reaching 27.86%. Despite insider sales totaling $6.2 million over the past 90 days, the company reported strong Q1 earnings, beating estimates with $0.43 EPS and $37.59 million in revenue, leading to a consensus "Moderate Buy" analyst rating and a target price of $67.50.

    MarketBeat•8/30/26•
    Somewhat-Bullish

    1,175,951 Shares in Eton Pharmaceuticals, Inc. $ETON Purchased by Nantahala Capital Management LLC

    Nantahala Capital Management LLC has acquired 1,175,951 shares of Eton Pharmaceuticals (NASDAQ:ETON), valued at approximately $42.6 million, representing a 4.29% stake in the company. Other institutional investors have also adjusted their positions, while company insiders have sold shares totaling $6.2 million in the last three months, though they still hold a 16.49% ownership. Analysts have a "Moderate Buy" rating for Eton Pharmaceuticals with an average price target of $67.50, following strong quarterly earnings that surpassed expectations.

    MarketBeat•8/29/26•
    Bullish

    Panoramic Capital LLC Takes $7.54 Million Position in Eton Pharmaceuticals, Inc. $ETON

    Panoramic Capital LLC has acquired a new position in Eton Pharmaceuticals, Inc. worth approximately $7.54 million, making it their 13th largest holding. Analysts maintain a "Moderate Buy" rating with an average price target of $67.50 for Eton, which recently surpassed quarterly earnings and revenue expectations. Despite this, some company insiders have recently sold shares, reducing their ownership.

    MarketBeat•8/27/26•
    Somewhat-Bullish

    Frequently Asked Questions About ETON

    Does ETON pay dividends?
    Eton Pharmaceuticals Inc (ETON) does not currently pay a regular dividend.
    What is ETON's P/E ratio?
    Eton Pharmaceuticals Inc has a price-to-earnings (P/E) ratio of 83.94.
    What is ETON's market cap?
    Eton Pharmaceuticals Inc (ETON) has a market capitalization of $1.73B with a current stock price of $60.44.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In